These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8422277)

  • 21. 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
    Nose H; Okada S; Okusaka T; Furuse J; Yoshino M; Ogoshi K; Kato T; Miyaji M; Hoshino M; Ariyama J; Suyama M; Karasawa E; Yoshimori M
    Hepatogastroenterology; 1999; 46(30):3244-8. PubMed ID: 10626195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic advances in pancreatic cancer: miles to go before we sleep.
    Bekaii-Saab T; Goldberg R
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25638250
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
    Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW
    BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced therapeutic effect of cis-diamminedichloroplatinum(II) against nude mouse grown human pancreatic adenocarcinoma when combined with 1-beta-D-arabinofuranosylcytosine and caffeine.
    Kyriazis AP; Kyriazis AA; Yagoda A
    Cancer Res; 1985 Dec; 45(12 Pt 1):6083-7. PubMed ID: 4063965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.
    Okusaka T; Okada S; Ishii H; Nose H; Nakasuka H; Nakayama H; Nagahama H
    Jpn J Clin Oncol; 1996 Aug; 26(4):215-20. PubMed ID: 8765178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced pancreatic cancer successfully treated with continuous infusion of 5-fluorouracil and low-dose cisplatin.
    Kikuchi H; Ujiie S; Kanamaru R
    Intern Med; 1998 Jul; 37(7):635-7. PubMed ID: 9711896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study.
    Rothman H; Cantrell JE; Lokich J; Difino S; Harvey J; Ahlgren J; Fryer J
    Cancer; 1991 Jul; 68(2):264-8. PubMed ID: 2070323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of locally advanced pancreatic cancer with FOLFIRINOX].
    Strobel O; Büchler MW
    Chirurg; 2016 Aug; 87(8):699. PubMed ID: 27418266
    [No Abstract]   [Full Text] [Related]  

  • 29. Keys to personalized care in pancreatic oncology.
    Crane CH; Iacobuzio-Donahue CA
    J Clin Oncol; 2012 Nov; 30(33):4049-50. PubMed ID: 23045599
    [No Abstract]   [Full Text] [Related]  

  • 30. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Sahoo RK; Kumar L
    N Engl J Med; 2014 Jan; 370(5):478-9. PubMed ID: 24476440
    [No Abstract]   [Full Text] [Related]  

  • 31. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Saltz LB; Bach PB
    N Engl J Med; 2014 Jan; 370(5):478. PubMed ID: 24476439
    [No Abstract]   [Full Text] [Related]  

  • 32. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Von Hoff DD; Goldstein D; Renschler MF
    N Engl J Med; 2014 Jan; 370(5):479-80. PubMed ID: 24476438
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
    Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M
    Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038
    [No Abstract]   [Full Text] [Related]  

  • 34. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer.
    Evans TR; Lofts FJ; Mansi JL; Glees JP; Dalgleish AG; Knight MJ
    Br J Cancer; 1996 May; 73(10):1260-4. PubMed ID: 8630289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in neoadjuvant and transformation therapy of pancreatic cancer].
    Hu DD; Dai MH
    Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):69-72. PubMed ID: 28056259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult.
    Boeck S; Haas M; Ormanns S; Kruger S; Siveke JT; Heinemann V
    Br J Cancer; 2014 Oct; 111(8):1675-6. PubMed ID: 24642615
    [No Abstract]   [Full Text] [Related]  

  • 38. Current management and future directions in metastatic pancreatic adenocarcinoma.
    Varghese AM; Lowery MA; Yu KH; O'Reilly EM
    Cancer; 2016 Dec; 122(24):3765-3775. PubMed ID: 27649047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation and chemotherapy. Treatment of localized pancreatic carcinoma.
    Blitzer PH; Dosoretz DE; Katin MJ; Rubenstein JH; Harwin WN; Raymond MG; Teufel TE; Seidenstein L; Mangano MM; Salenius SA
    J Fla Med Assoc; 1994 Jun; 81(6):403-7. PubMed ID: 8064281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
    Taïeb J; Lecomte T; Ezenfis J; Artru P; Mitry E; Boige V; Clavero-Fabri MC; Vaillant JN; Rougier P; Ducreux M
    Gastroenterol Clin Biol; 2002; 26(6-7):605-9. PubMed ID: 12193860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.